×
Choose Speciality

EXPLORE!

LOGIN

By signing up or signing in to eMediNexus, you consent to eMediNexus collecting and using your personal data in accordance with our Privacy Policy. I consent to receive medical updates and communications from eMediNexus, it's parent company IJCP and its industry partners.

Zydus' Jarod manufacturing unit receives 3 observations from USFDA

  752 Views

Viswanath Pilla    11 March 2022

On Thursday, Zydus Lifesciences said it had received 3 observations from USFDA, after inspecting the injectable facility at Jarod (Vadodara) manufacturing unit from February 24 to March 10, 2022.

Zydus Lifesciences said that they were confident about resolving the issues and would satisfy the USFDA. They would remain committed to building a quality culture across all their manufacturing network and we′re committed to remain compliant with high standards of good manufacturing practices across their network.

If the investigators observed any conditions, the USFDA issued its observations through Form 483 after the inspection.

Source: ET Healthworld

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.